What is HC Wainwright’s Forecast for CDTX FY2029 Earnings?
Cidara Therapeutics, Inc. (NASDAQ:CDTX – Free Report) – Investment analysts at HC Wainwright issued their FY2029 EPS estimates for shares of Cidara Therapeutics in a report issued on Monday, March 10th. HC Wainwright analyst E. Arce anticipates that the biotechnology company will earn ($1.96) per share for the year. HC Wainwright currently has a “Buy” […]
